Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT1) receptors

Journal of Human Hypertension volume 16, pages 261–266 (2002)Cite this article

Abstract

The objective of this study was to examine the effect of angiotensin II (Ang II) and angiotensin II type 1 (AT1) receptor blockade on pulse wave velocity (PWV) in healthy humans. We studied nine young male volunteers in a double-blind randomised crossover design. Carotid-femoral PWV (an index of arterial stiffness) was measured by using a Complior® machine. Subjects were previously treated for 3 days with once-daily dose of either a placebo or valsartan 80 mg. On the third day, they were infused with either placebo or 5 ng/kg/min of Ang II over 30 min. Subjects thus received placebo capsule + placebo infusion (P), valsartan + placebo infusion (V), placebo + Ang II infusion (A), and valsartan + Ang II infusion (VA) combinations. Heart rate (HR), blood pressure and PWV were recorded at baseline and then every 10 min during infusion and once after the end of infusion. There were significant increases in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) with A compared with P (P = 0.002, P = 0.002, P = 0.001 respectively). These rises in blood pressure were completely blocked by valsartan. A significant rise in PWV by A was seen compared with P (8.38 ± 0.24 vs 7.48 ± 0.24 m/sec, P = 0.013) and was completely blocked by valsartan; VA compared with P (7.27 ± 0.24 vs 7.48 ± 0.24 m/sec, P = NS). Multiple linear regression analysis showed that blockade of Ang II induced increase in blood pressure by valsartan contributed to only 30% of the total reduction in Ang II induced rise in PWV (R2 = 0.306). The conclusions were that valsartan completely blocks the effect of Ang II on PWV. The effect of Ang II on PWV is mediated through AT1receptors. Reduction in PWV by Ang II antagonist is not fully explained by its pressure lowering effect of Ang II and may be partially independent of its effect on blood pressure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Asmar RG et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension Circulation 1988 78: 941–950

    Article  CAS  Google Scholar 

  2. Perret F et al. Evaluation of arterial compliance-Pressure curves: effect of antihypertensive drugs Hypertension 1991 18 (Suppl II): II-77–II-83

    Google Scholar 

  3. Naftilan AJ, Pratt RE, Dzau VJ . Induction of platelet derived growth factor A-Chain and C-myc gene expressions by angiotensins in cultured rat vascular smooth muscle cells J Clin Invest 1989 83: 1419–1424

    Article  CAS  Google Scholar 

  4. Bunkenberg B, Van Acmisoort T, Rogg FF, Wood JM . Receptor mediated effects of angiotensin II from spontaneously hypertensive rats Hypertension 1992 20: 746–754

    Article  Google Scholar 

  5. Benetos A et al. Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphism on aortic stiffness in normotensive and hypertensivepatients Circulation 1996 94: 698–703

    Article  CAS  Google Scholar 

  6. Rehman A, Rahman ARA, Rasool AHG . The effect of angiotensin II on pulse wave velocity in healthy human; a placebo controlled dose response study J Hypertens 2000 18 (Suppl 4): S87

    Google Scholar 

  7. Rahman ARA, Motwani JG, Lang CC, Struthers AD . Circulating angiotensin II and renal sodium handling in man: a dose-response study Clin Sci 1993 85: 147–156

    Article  CAS  Google Scholar 

  8. Jilma B et al. Effects of angiotensin II infusion at pressor and subpressor doses on endothelin 1 plasma levels in healthy men Life Sci 1997 60: 1859–1866

    Article  CAS  Google Scholar 

  9. Asmar R et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement; validation and clinical application studies Hypertension 1995 26: 485–490

    Article  CAS  Google Scholar 

  10. Ngim CA, Rahman ARA, Ibrahim A . Pulse wave velocity as an index of arterial stiffness: a comparison between newly diagnosed (untreated) hypertensives and normotensive middle aged Malay men and its relationship with fasting insulin Acta Cardiol 1999 54: 277–282

    CAS  PubMed  Google Scholar 

  11. Asmar R et al. Reversion of arterial abnormalities by long-term antihypertensive therapy in large population – the Complior® study J Hypertens 1999 17 (Suppl 3): S9–S10

    Google Scholar 

  12. Liang YL et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size Clin Sci 1998 95: 669–679

    Article  CAS  Google Scholar 

  13. Young MJ, Bresnitz EA, Strom BL . Sample size normograms for interpreting negative clinical studies Annals Int Med 1983 99: 248–251

    Article  CAS  Google Scholar 

  14. Ohman KP, Karlberg BE . Circulating plasma prekallikrein and tissue kallikrein in normotensive human: effects of angiotensin II infusion Clin Exper Hypertens 1998 20: 313–328

    Article  CAS  Google Scholar 

  15. Muller P et al. Pharmacokinetics and pharmacodynamic effects of angiotensin II antagonist valsartan at steady state in healthy normotensive subjects Eur J Clin Pharmacol 1997 52: 441–449

    Article  CAS  Google Scholar 

  16. Rasool et al. Ethnic differences in response to non selective β-blockade among racial groups in Malaysia Int J Clin Pharmacol Ther 2000 38: 260–269

    Article  CAS  Google Scholar 

  17. Shiels P et al. Angiotensin II receptor subtype 1 antagonism and diastolic cardiac filling in man Br J Clin Pharmacol 1999 47: 337–338

    CAS  PubMed  Google Scholar 

  18. Morgan JM et al. The effect of valsartan on the angiotensin II pressor response in healthy normotensive subjects Clin Pharmacol Ther 1997 61: 35–44

    Article  CAS  Google Scholar 

  19. Barra JB et al. In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity Am J Physiol 1997 272: H859–H868

    CAS  PubMed  Google Scholar 

  20. Pratt RE . Angiotensin II and control of cardiovascular structure J Am Soc Nephrol 1999 10 (Suppl 11): S120–S126

    Google Scholar 

  21. Hein L et al. Behavioral and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice Nature 1995 377: 744–747

    Article  CAS  Google Scholar 

  22. Ichiki T et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type II receptor Nature 1995 377: 748–750

    Article  CAS  Google Scholar 

  23. Gohlke P, Pees C, Unger T . AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin dependent mechanism Hypertension 1998 31: 349–355

    Article  CAS  Google Scholar 

  24. Barber MN, Sampey DB, Widdop RE . AT2 receptor stimulation enhances anithypertensive effect of AT1 antagonists in hypertensive rats Hypertension 1999 34: 1112

    Article  CAS  Google Scholar 

  25. Benetos A, Gautier S, Lafleche A, Topouchian J . Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans J Vasc Res 2000 37: 8–18

    Article  CAS  Google Scholar 

  26. Mahmud A, Feely J . Reduced vascular stiffness by angiotensin II receptor blockade in uncontrolled hypertension Br J Clin Pharmacol 1999 47: 586

    Google Scholar 

  27. Meaney E et al. Increased arterial stiffness in children with a parental history of hypertension Pediatric Cardiol 1999 20: 203–205

    Article  CAS  Google Scholar 

  28. Rajzer MW et al. Aortic pulse wave velocity in young normotensives with a family history of hypertension J Hypertens 1999 17: 1821–1824

    Article  CAS  Google Scholar 

  29. Okunishi H et al. Marked species-difference in the vascular angiotensin II forming pathways: human versus rodents Jpn J Pharmacol 1993 62: 207–210

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from Universiti Sains Malaysia (Grant no; 361–9641–1041).

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Medical Science, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

    A Rehman, A R A Rahman & A H G Rasool

Authors
  1. A Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A R A Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A H G Rasool
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Rehman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rehman, A., Rahman, A. & Rasool, A. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT1) receptors. J Hum Hypertens 16, 261–266 (2002). https://doi.org/10.1038/sj.jhh.1001372

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001372

Keywords

Search

Advanced search

Quick links